Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q3 2016
|
ABUS |
|
Phase 2 Results |
Infectious Disease |
None |
|
Q3 2016
|
TBRA |
|
Phase 2b Results |
Endocrine |
Fast Track |
|
Q3 2016
|
CERU |
|
Phase 2 Results |
Oncology |
Fast Track, Orphan Drug |
|
Q3 2016
|
ACHN |
|
Phase 2a Results |
Infectious Disease |
None |
|
Q3 2016
|
ACRX |
|
Phase 3 Results |
Other |
None |
|
Q3 2016
|
AEZS |
|
Phase 3 Results |
Oncology |
None |
|
10/14/2016
|
EGLT |
|
PDUFA |
Neurology |
None |
|
10/22/2016
|
MDVN |
|
PDUFA |
Oncology |
None |
|
10/22/2016
|
OPK |
|
PDUFA |
Endocrine |
None |
|
10/27/2016
|
PRQR |
|
Phase 1b Results |
Other |
Fast Track, Orphan Drug |
|